Evidence map›Paper›PMID 40521510›Full record

ArticleACS omega2025

Discovery and Exploration of Small Molecule Binders for CT83: Computational Insights from Homology Modeling, Virtual Screening, MD Simulations, Interaction Fingerprint, and Network Communications.

Varun Dewaker, Sung Taek Park, Jae Jun Lee, Hyeong Su Kim

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Varun DewakerInstitute of New Frontier Research, College of Medicine, Hallym University, Chuncheon-Si, Gangwon-Do 24252, Republic of Korea.ORCID https://orcid.org/0000-0003-1571-974X
Sung Taek ParkInstitute of New Frontier Research, College of Medicine, Hallym University, Chuncheon-Si, Gangwon-Do 24252, Republic of Korea.
Jae Jun LeeInstitute of New Frontier Research, College of Medicine, Hallym University, Chuncheon-Si, Gangwon-Do 24252, Republic of Korea.
Hyeong Su KimInstitute of New Frontier Research, College of Medicine, Hallym University, Chuncheon-Si, Gangwon-Do 24252, Republic of Korea.ORCID https://orcid.org/0000-0003-0553-9008

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kita-Kyushu lung cancer antigen-1 (KK-LC-1), also known as CT83, is a member of the cancer/testis antigen (CTA) family and has emerged as an important target for cancer therapy. Its expression is typically restricted to certain cancers, including nonsmall cell lung cancer, gastric cancer, triple-negative breast cancer, and testicular tissues, making it an attractive candidate for targeted drug development against cancer cells. We identified several new small molecules using PubChem chemical property searches, Lipinski rule-based filtration, virtual screening, molecular docking, and molecular dynamics (MD) simulations, with reference to the compound Z839878730 reported in the literature. The selected molecules were CID24326943, CID24459131, CID46375999, CID46533890, and CID55836895. MD simulations (200 ns) revealed stable CT83-ligand complexes, with MMPBSA calculations showing that Z839878730, CID24459131, and CID46375999 exhibited the most favorable relative binding free energies. Among these, CID46375999 shared greater similarity with the reference compound, featuring a 1,3,4-thiadiazole-2-carboxamide scaffold, hydrophobic properties, and hydrogen bonding potential. In contrast, CID24459131, which features an imidazolidinone ring and relatively bulky substituents such as a diphenylethyl moiety, exhibits a more flexible and extended conformation. Although CID46375999 contains a piperidine ring, its overall structure is more conformationally constrained compared to CID24459131, likely due to fewer rotatable bonds and a more compact architecture. Overall, CID46375999 aligned more closely with the reference compound in terms of chemical properties. Interaction fingerprint analysis revealed frequent interactions with key residues Leu15, Ile16, Phe18, Trp19, Arg22, Leu38, Arg42, Pro43, Arg76, Gln77, and Ile80, including hydrophobic interactions, π-stacking (Phe18 and Trp19), and H-bonds (Arg22, Arg76, Gln77, and Ser44), and the communication network of these interactions provided insights into binding dynamics.

Identifiers

PMID40521510
PMCPMC12163856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.